{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:09:25Z","timestamp":1785510565960,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2019-01-07-00-07-E00046"],"award-info":[{"award-number":["2019-01-07-00-07-E00046"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273515"],"award-info":[{"award-number":["82273515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273510"],"award-info":[{"award-number":["82273510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jval.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:35:22Z","timestamp":1764779722000},"page":"366-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Ixekizumab Versus Ustekinumab in Patients With Psoriasis: A Randomized Controlled Trial Replication Using Data From an Observational Study (Shanghai Psoriasis Effectiveness Evaluation Cohort)"],"prefix":"10.1016","volume":"29","author":[{"given":"Ning","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jval.2025.11.009_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaad.2015.12.017","article-title":"Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])","volume":"74","author":"Strober","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"34","key":"10.1016\/j.jval.2025.11.009_bib2","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2012.42.2352","article-title":"Randomized controlled trials and comparative effectiveness research","volume":"30","author":"Hahn","year":"2012","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jval.2025.11.009_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.jval.2025.11.009_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cpt.857","article-title":"When and how can real world data analyses substitute for randomized controlled trials?","volume":"102","author":"Franklin","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jval.2025.11.009_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cpt.1633","article-title":"Nonrandomized real-world evidence to support regulatory decision making: process for a randomized trial replication project","volume":"107","author":"Franklin","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jval.2025.11.009_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7326\/ANNALS-24-01871","article-title":"The target trial framework for causal inference from observational data: why and when is it helpful?","volume":"178","author":"Hern\u00e1n","year":"2025","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib7","article-title":"A causal roadmap for generating high-quality real-world evidence","volume":"7","author":"Dang","year":"2023","journal-title":"J Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jdv.15174","article-title":"Head-to-head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences","volume":"33","author":"Wan","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamadermatol.2020.4202","article-title":"Randomized trial replication using observational data for comparative effectiveness of secukinumab and ustekinumab in psoriasis: a study from the British Association of Dermatologists biologics and immunomodulators register","volume":"157","author":"Yiu","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jval.2025.11.009_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/bjd.15666","article-title":"Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study","volume":"177","author":"Reich","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2018.06.039","article-title":"Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: results from IXORA-S, a phase 3 study","volume":"80","author":"Paul","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jval.2025.11.009_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/cpt.1793","article-title":"Emulation Differences vs. biases When Calibrating Real-World Evidence Findings against Randomized Controlled Trials","volume":"107","author":"Franklin","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jval.2025.11.009_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/bjd\/ljad188","article-title":"Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis","volume":"189","author":"Yu","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"5","key":"10.1016\/j.jval.2025.11.009_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hernan","year":"2000","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.jval.2025.11.009_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/rssb.12027","article-title":"Covariate balancing propensity score","volume":"76","author":"Imai","year":"2013","journal-title":"J R Stat Soc B"},{"issue":"8 suppl","key":"10.1016\/j.jval.2025.11.009_bib18","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research","volume":"66","author":"Stuart","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.jval.2025.11.009_bib19","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib20","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1106","article-title":"Missing confounding data in marginal structural models: a comparison of inverse probability weighting and multiple imputation","volume":"4","author":"Moodie","year":"2008","journal-title":"Int J Biostat"},{"issue":"10","key":"10.1016\/j.jval.2025.11.009_bib21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","article-title":"Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative","volume":"143","author":"Franklin","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/biomet\/asn055","article-title":"Dealing with limited overlap in estimation of average treatment effects","volume":"96","author":"Crump","year":"2009","journal-title":"Biometrika"},{"issue":"8","key":"10.1016\/j.jval.2025.11.009_bib23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/aje\/kwab041","article-title":"Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: a simulation study","volume":"190","author":"St\u00fcrmer","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.jval.2025.11.009_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/biomet\/75.2.383","article-title":"A stagewise rejective multiple test procedure based on a modified Bonferroni test","volume":"75","author":"Hommel","year":"1988","journal-title":"Biometrika"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2530647","article-title":"The bias due to incomplete matching","volume":"41","author":"Rosenbaum","year":"1985","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.jval.2025.11.009_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"6","key":"10.1016\/j.jval.2025.11.009_bib27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0272989X09341755","article-title":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies","volume":"29","author":"Austin","year":"2009","journal-title":"Med Decis Mak"},{"issue":"28","key":"10.1016\/j.jval.2025.11.009_bib28","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jval.2025.11.009_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000348","article-title":"SLE clinical trials: impact of missing data on estimating treatment effects","volume":"6","author":"Kim","year":"2019","journal-title":"Lupus Sci Med"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525061418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525061418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:00:00Z","timestamp":1778086800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525061418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1098301525061418"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.11.009","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness of Ixekizumab Versus Ustekinumab in Patients With Psoriasis: A Randomized Controlled Trial Replication Using Data From an Observational Study (Shanghai Psoriasis Effectiveness Evaluation Cohort)","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}